Literature DB >> 12499429

Detection of telomerase, its components, and human papillomavirus in cervical scrapings as a tool for triage in women with cervical dysplasia.

N Reesink-Peters1, M N Helder, G B A Wisman, A J Knol, S Koopmans, H M Boezen, E Schuuring, H Hollema, E G E de Vries, S de Jong, A G J van der Zee.   

Abstract

AIM: To examine whether the detection of either telomerase and its components or high risk human papillomavirus (HPV) are of value in predicting the presence of cervical intraepithelial neoplasia (CIN) grade II/III in women referred because of cervical cytology reports showing at most moderate dyskaryosis.
METHODS: Cervical scrapings of 50 women referred with cytological borderline, mild, or moderate dyskaryosis were analysed. Telomerase activity was assessed by a commercially available telomere repeat amplification protocol assay and its components human telomerase RNA (hTR) and human telomerase reverse transcriptase (hTERT) were assessed by reverse transcriptase polymerase chain reaction (PCR). HPV was detected by GP5+/6+ PCR enzyme immunosassay. Histological findings on colposcopy guided biopsies or excised cervical tissue were regarded as the final pathological diagnosis. The sensitivity and specificity for detecting CIN II/III were calculated.
RESULTS: Twenty eight women were diagnosed with CIN II/III. Telomerase activity was detected in none, hTR in 88%, hTERT in 23%, and high risk HPV was detected in 79% of these women. As a diagnostic test none of the described analyses combined a sensitivity of at least 90% with a specificity >or= 90%. Despite the small numbers, calculation of the 95% confidence intervals excluded a combined sensitivity and specificity of at least 90% for all of the evaluated parameters.
CONCLUSIONS: Neither detection of telomerase or its components, nor detection of high risk HPV seem suitable for the triage of women with borderline, mild, and moderate cytological dyskaryosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12499429      PMCID: PMC1769855          DOI: 10.1136/jcp.56.1.31

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  29 in total

1.  Telomerase activity in Papanicolaou smear-negative exfoliated cervical cells and its association with lesions and oncogenic human papillomaviruses.

Authors:  P S Zheng; T Iwasaka; Z M Zhang; A Pater; H Sugimori
Journal:  Gynecol Oncol       Date:  2000-06       Impact factor: 5.482

2.  A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings.

Authors:  M V Jacobs; P J Snijders; A J van den Brule; T J Helmerhorst; C J Meijer; J M Walboomers
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

3.  Extension of life-span by introduction of telomerase into normal human cells.

Authors:  A G Bodnar; M Ouellette; M Frolkis; S E Holt; C P Chiu; G B Morin; C B Harley; J W Shay; S Lichtsteiner; W E Wright
Journal:  Science       Date:  1998-01-16       Impact factor: 47.728

4.  Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA.

Authors:  P J Snijders; M van Duin; J M Walboomers; R D Steenbergen; E K Risse; T J Helmerhorst; R H Verheijen; C J Meijer
Journal:  Cancer Res       Date:  1998-09-01       Impact factor: 12.701

5.  Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study.

Authors:  M A Nobbenhuis; J M Walboomers; T J Helmerhorst; L Rozendaal; A J Remmink; E K Risse; H C van der Linden; F J Voorhorst; P Kenemans; C J Meijer
Journal:  Lancet       Date:  1999-07-03       Impact factor: 79.321

6.  Reconstitution of human telomerase activity in vitro.

Authors:  T L Beattie; W Zhou; M O Robinson; L Harrington
Journal:  Curr Biol       Date:  1998-01-29       Impact factor: 10.834

7.  Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase.

Authors:  C M Counter; M Meyerson; E N Eaton; L W Ellisen; S D Caddle; D A Haber; R A Weinberg
Journal:  Oncogene       Date:  1998-03-05       Impact factor: 9.867

8.  Comparison of human telomerase RNA and telomerase activity in urine for diagnosis of bladder cancer.

Authors:  M Müller; H Krause; R Heicappell; J Tischendorf; J W Shay; K Miller
Journal:  Clin Cancer Res       Date:  1998-08       Impact factor: 12.531

9.  Telomerase activity as a biomarker for (pre)neoplastic cervical disease in scrapings and frozen sections from patients with abnormal cervical smear.

Authors:  G B Wisman; H Hollema; S de Jong; J ter Schegget; S P Tjong-A-Hung; M H Ruiters; M Krans; E G de Vries; A G van der Zee
Journal:  J Clin Oncol       Date:  1998-06       Impact factor: 44.544

10.  Telomerase activity in gynecological tumors.

Authors:  S Kyo; T Kanaya; H Ishikawa; H Ueno; M Inoue
Journal:  Clin Cancer Res       Date:  1996-12       Impact factor: 12.531

View more
  10 in total

1.  Potential of telomerase expression and activity in cervical specimens as a diagnostic tool.

Authors:  S Bravaccini; M A Sanchini; A Amadori; L Medri; L Saragoni; D Calistri; F Monti; A Volpi; D Amadori
Journal:  J Clin Pathol       Date:  2005-09       Impact factor: 3.411

Review 2.  Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers.

Authors:  J P A Baak; A-J Kruse; S J Robboy; E A M Janssen; B van Diermen; I Skaland
Journal:  J Clin Pathol       Date:  2006-05-05       Impact factor: 3.411

3.  Telomerase activity as a potential diagnostic marker for triage of abnormal Pap smears.

Authors:  Kevin A Ault; Heather K Allen; Stacia L Phillips; M Bridget Zimmerman; Aloysius J Klingelhutz
Journal:  J Low Genit Tract Dis       Date:  2005-04       Impact factor: 1.925

4.  Telomerase activity as a tumor marker in Indian women with cervical intraepithelial neoplasia and cervical cancer.

Authors:  Alpana Sharma; Medha Rajappa; Alpana Saxena; Manoj Sharma
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

5.  Clinical significance of hTERC gene amplification detection by FISH in the screening of cervical lesions.

Authors:  Yuan Zhang; Xiaobei Wang; Ling Ma; Zehua Wang; Lihua Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-06-10

6.  hTERT promoter activity and CpG methylation in HPV-induced carcinogenesis.

Authors:  Jillian de Wilde; Jan M Kooter; Renée M Overmeer; Debbie Claassen-Kramer; Chris J L M Meijer; Peter J F Snijders; Renske D M Steenbergen
Journal:  BMC Cancer       Date:  2010-06-09       Impact factor: 4.430

7.  Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia.

Authors:  Kerstin Heselmeyer-Haddad; Viktor Janz; Philip E Castle; Nadia Chaudhri; Nicole White; Kim Wilber; Larry E Morrison; Gert Auer; Frances H Burroughs; Mark E Sherman; Thomas Ried
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

8.  Chromosome in situ hybridisation, Ki-67, and telomerase immunocytochemistry in liquid based cervical cytology.

Authors:  A N Y Cheung; P M Chiu; K L Tsun; U S Khoo; B S Y Leung; H Y S Ngan
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

9.  Immunohistochemical expression of ubiquitin and telomerase in cervical cancer.

Authors:  Toro de Méndez Morelva; Llombart Bosch Antonio
Journal:  Virchows Arch       Date:  2009-08-14       Impact factor: 4.064

10.  The significant diagnostic value of human telomerase RNA component (hTERC) gene detection in high-grade cervical lesions and invasive cancer.

Authors:  Xiaobin Wang; Jia Liu; Hong Xi; Liping Cai
Journal:  Tumour Biol       Date:  2014-04-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.